Cureus · 2021 · 11 citations · 18 references
MedicinePharmacotherapyClinical PharmacologyHepatic PharmacotherapyMetabolic RegulationCirrhosisInsulin ResistanceLipid-lowering TherapyLiver DiseaseMetabolic Liver DiseaseMetabolic SyndromeFatty AcidsImpaired Insulin SensitivityOmega-3 Fatty AcidsSteatosis Quantification
Metabolic-associated fatty liver disease (MAFLD) is increasingly common among people living with the human immunodeficiency virus (PLHIV) and can progress to cirrhosis and cirrhotic-related complications. Pioglitazone is known to improve insulin sensitivity that results in decreasing serum fatty acids and resolution of non-alcoholic steatohepatitis. This study was aimed to evaluate the efficacy of pioglitazone for the treatment of MAFLD in PLHIV and prediabetes.
18